Thus, transcriptional inhibition of the Pax6 in beta cells may represent as one of the key pathogenic mechanism for the Smad3-driven beta cell loss and dysfunction in type 2 diabetes. The gene discussed is PAX6; the disease is type 2 diabetes mellitus.